Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Catalent Inc
(NY:
CTLT
)
60.29
+0.20 (+0.33%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
908,424
Open
60.00
Bid (Size)
60.00 (2)
Ask (Size)
61.03 (1)
Prev. Close
60.09
Today's Range
59.95 - 60.39
52wk Range
31.80 - 61.20
Shares Outstanding
170,341,553
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
October 18, 2024
Public interest groups are urging the FTC to block Novo Holdings' $16.5 billion acquisition of Catalent, citing concerns over reduced competition in critical areas like diabetes, obesity treatments,...
Via
Benzinga
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
October 15, 2024
Jim Cramer believes Uranium Energy Corp. is going higher, thanks to a recent acquisition deal. Novo Nordisk faces antitrust concerns while Halliburton gets a Buy rating from BofA Securities.
Via
Benzinga
Performance
YTD
+33.83%
+33.83%
1 Month
+0.30%
+0.30%
3 Month
+3.54%
+3.54%
6 Month
+7.56%
+7.56%
1 Year
+43.00%
+43.00%
More News
Read More
Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility
October 14, 2024
From
Catalent, Inc.
Via
Business Wire
FTC Faces Pressure to Block Novo Nordisk-Catalent Merger Over Antitrust Fears
October 10, 2024
Via
Benzinga
Beyond The Numbers: 6 Analysts Discuss Catalent Stock
April 04, 2024
Via
Benzinga
Four Stocks To Watch This Week - Tuesday, Oct. 01
October 01, 2024
Via
Talk Markets
Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
September 16, 2024
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results
August 29, 2024
From
Catalent, Inc.
Via
Business Wire
Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater
August 16, 2024
Via
The Motley Fool
Catalent Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, Germany
July 16, 2024
From
Catalent, Inc.
Via
Business Wire
Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty
June 21, 2024
Via
Benzinga
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
June 01, 2024
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Catalent Stockholders Approve Transaction with Novo Holdings
May 29, 2024
From
Catalent, Inc.
Via
Business Wire
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
May 28, 2024
Via
The Motley Fool
Hedge Funds Tweak Portfolios In Q1: Marvell, TD Synnex, AES Get More Love As Focus Shifts To AI
May 24, 2024
Via
Benzinga
CTLT Stock Earnings: Catalent Misses EPS, Misses Revenue for Q3 2024
May 09, 2024
Via
InvestorPlace
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
May 08, 2024
From
Catalent, Inc.
Via
Business Wire
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
May 02, 2024
Via
Benzinga
Robbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT)
April 17, 2024
From
Robbins LLP
Via
Business Wire
Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating
April 12, 2024
Via
Benzinga
Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings
April 10, 2024
From
Robbins LLP
Via
GlobeNewswire
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
March 26, 2024
Via
The Motley Fool
Week In Review: Three Multinationals Plan Investments In Southeast Asia Facilities
March 23, 2024
Via
Talk Markets
Did Novo Nordisk Just Get a Jump on Eli Lilly?
March 19, 2024
Via
The Motley Fool
Exposures
Product Safety
The Top 3 Pharma Stocks to Buy in March2024
March 09, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.